HDAC3 inhibition up-regulates PD-L1 expression in B-cell lymphomas and augments the efficacy of anti-PD-L1 therapy
Deng, Siyu, Hu, Qianwen, Zhang, Heng, Yang, Fang, Peng, Cheng, Huang, ChuanxinLanguage:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-18-1068
Date:
March, 2019
File:
PDF, 2.50 MB
english, 2019